Elevated C-Reactive Protein Levels and Increased Cardiovascular Risk in Patients With Obstructive Sleep Apnea Syndrome
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular morbidity and mortality. Inflammatory processes associated with OSAS may contribute to cardiovascular morbidity in these patients. C-reactive protein (CRP) is an important serum marker of inflammation. We tested the hypothesis that patients with OSAS have increased plasma CRP. After 173 male subjects underwent polysomnography, 94 were considered to have OSAS (apnea-hypopnea index (AHI) > 5), 38 cardiovascular disease (CVD), and 56 without CVD. Seventy-nine subjects were considered not to have OSAS (AHI < 5) and from among these 57 patients without CVD were enrolled as control subjects. Serum CRP levels were significantly elevated in the OSAS + CVD group compared to the two other groups (P < 0.05). When we evaluated the association between the serum CRP level and severity of OSAS, CRP levels were positively correlated with AHI in OSAS patients (r = 0.61, P < 0.001) OSAS, as a marker of inflammation and cardiovascular risk, is associated with elevated levels of CRP. According to these results, the link between cardiovascular morbidity and OSAS may be explained by the coexistence of other cardiovascular risk factors such as circulating CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3950 · Cited by 974
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea
Shamsuzzaman, A. S. M., Winnicki, M., Lanfranchi, P., Wolk, R., Kara, T., Accurso, V., & Somers, V. K. (2002) · Circulation · doi:10.1161/01.cir.0000018948.95175.03 · Cited by 974
Cited by
Serum Inflammatory Markers in Obstructive Sleep Apnea: A Meta-Analysis
Nadeem, R., Molnar, J., Madbouly, E. M., Nida, M., Aggarwal, S., Sajid, H., Naseem, J., & Loomba, R. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3070 · Cited by 481
Brain Structural Changes in Obstructive Sleep Apnea
(2008) · Sleep · doi:10.5665/sleep/31.7.967 · Cited by 376
Mulgrew, A. T., Fox, N., Ayas, N. T., & Ryan, C. F. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-3-200702060-00004 · Cited by 368
“Obstructive sleep apnea may result in a systemic inflammatory state that predisposes the patient to cardiac and cerebrovascular conditions (3).”
BackgroundGarvey, J. F., Taylor, C. T., & McNicholas, W. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00111208 · Cited by 356
Ryan, S., Taylor, C. T., & McNicholas, W. T. (2009) · Postgraduate Medical Journal · doi:10.1136/thx.2008.105577 · Cited by 339
Inflammation, sleep, obesity and cardiovascular disease
Miller, M., & Cappuccio, F. (2007) · Current Vascular Pharmacology · doi:10.2174/157016107780368280 · Cited by 233
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Parati, G., Lombardi, C., & Narkiewicz, K. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00400.2007 · Cited by 205
Wang, J., Yu, W., Gao, M., Zhang, F., Gu, C., Yu, Y., & Wei, Y. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002454 · Cited by 168
“The control group included persons without OSAS.”
BackgroundInfluentialBaessler, A., Nadeem, R., Harvey, M., Madbouly, E., Younus, A., Sajid, H., Naseem, J., Asif, A., & Bawaadam, H. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-13 · Cited by 165
“Many studies have reported that patients with OSA have increased levels of mediators of the systemic inflammatory response, including cell adhesion molecules (ICAM), coagulation factors (Factor VIII, Tissue factor), and C-reactive protein (CRP) [18-20].”
BackgroundNon-dipping pattern of hypertension and obstructive sleep apnea syndrome
Wolf, J., Hering, D., & Narkiewicz, K. (2010) · Hypertension Research · doi:10.1038/hr.2010.153 · Cited by 156
Liukkonen, T., Räsänen, P., Ruokonen, A., Laitinen, J., Jokelainen, J., Leinonen, M., Meyer-Rochow, V. B., & Timonen, M. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318157cb96 · Cited by 83
Bilgir, O., Bilgir, F., Calan, M., Calan, O. G., & Yuksel, A. (2015) · Clinics · doi:10.6061/clinics/2015(02)05 · Cited by 54
“In many trials conducted in diverse groups, a strong correlation was found between CRP levels and cardiovascular disease (24).”
BackgroundFalcone, V. A., Damiani, M. F., Quaranta, V. N., Capozzolo, A., & Resta, O. (2014) · Respiratory Care · doi:10.4187/respcare.02491 · Cited by 33
Daulatzai, M. A. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9528-x · Cited by 12
“Ethanol treatment interferes with matrix metalloproteinases (MMP-9) activity in the hippocampus (Wright et al. 2003).”
Background
Metadata
- Authors
- Kokturk, O., Ciftci, T. U., Mollarecep, E., & Ciftci, B.
- Venue
- International Heart Journal
- Published
- 2005
- Volume
- 46
- Issue
- 5
- Pages
- 801-809
- ISSN
- 1349-2365 (ISSN-L)
- 1349-3299
- OpenAlex
- W1993505686
- Cited by
- 151
- References
- 6
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.